Amifampridine

Therapeutic indications

Amifampridine is indicated for:

Lambert-Eaton myasthenic syndrome (LEMS)

Population group: both men and women, only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Amifampridine is contraindicated in the following cases:

Epilepsy

Uncontrolled asthma

Sultopride

Medicinal products that can prolong QTc interval

Congenital QT syndrome

Medicinal products with a narrow therapeutic window